Vir Biotechnology

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company based in San Francisco, California. Founded in 2017, the company focuses on developing innovative medicines that harness the human immune system to tackle significant unmet medical needs, particularly in infectious diseases and oncology. Vir aims to create a world without infectious disease by utilizing advanced biological tools, including next-generation antibody engineering and its proprietary PRO-XTEN™ technology. The company develops antibody-based therapies and protease-releasable masked therapeutics targeting various conditions, including chronic hepatitis delta, hepatitis B, and solid tumors. Vir has advanced multiple drug candidates into clinical trials for diseases such as COVID-19, Ebola, and tuberculosis. With a dedicated workforce of over 200 employees, Vir is committed to improving patient outcomes globally by addressing critical health challenges through its innovative therapeutic programs.

Research San Francisco, United States ~375 employees NASDAQ: VIR

Work at Vir Biotechnology in HR or recruiting? Claim this page

Employees
375
+0.5% in the 3 months to Sep 2026
Revenue / employee
$49.4K
Revenue ~$18.5M
Stock
VIR
NASDAQ
12-month attrition
15.1%
Tech: 9.4%
H1B filings, FY2026
2
Sponsors visas
Open jobs
5
Last 30 days

Headcount trend

Vir Biotechnology went from 410 employees in Oct 2024 to 375 in Sep 2026. Apr to Sep 2026: 22 people joined, 14 left.

Org structure

Headcount by department

Other226
Operations84
Finance21
Engineering18
HR11
Sales10
Marketing4
Success1

Executive compensation

Salaries at Vir Biotechnology

All salaries

1 salary profiles in the US

Pay by level, gender and ethnicity

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering10
Operations3

The department split adds up all the years listed above. FY2026 alone: 2 filings.

Peer reviews

Worked with someone at Vir Biotechnology?

Anonymous peer reviews on OffTheRecord

Read or write a review

Hiring now

Similar companies

Vir Biotechnology FAQ

How many employees does Vir Biotechnology have?

Vir Biotechnology has about 375 employees, up 0.5% over the 3 months to Sep 2026.

Does Vir Biotechnology sponsor H1B visas?

Yes. Vir Biotechnology filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.

What is Vir Biotechnology's revenue per employee?

Vir Biotechnology makes about $49K in revenue per employee, based on $18.53M annual revenue and 375 employees.

How much does Vir Biotechnology pay?

6figr has 1 salary profile for Vir Biotechnology in the US, with pay broken down by role, level, gender and ethnicity on the Vir Biotechnology salaries page. See Vir Biotechnology salaries

Is Vir Biotechnology a public company?

Yes. Vir Biotechnology is publicly traded under the ticker VIR on NASDAQ.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.